Published: Jan. 1, 2024
Language: Английский
Published: Jan. 1, 2024
Language: Английский
Published: April 9, 2025
Language: Английский
Citations
0Theriogenology, Journal Year: 2025, Volume and Issue: 242, P. 117442 - 117442
Published: April 11, 2025
Language: Английский
Citations
0bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 22, 2024
ABSTRACT Painful diabetic neuropathy (PDN) is a challenging complication of diabetes with patients experiencing painful and burning sensation in their extremities. Existing treatments provide limited relief without addressing the underlying mechanisms disease. PDN involves gradual degeneration nerve fibers skin. Keratinocytes, most abundant epidermal cell type, are closely positioned to cutaneous terminals, suggesting possibility bi-directional communication. Exosomes small extracellular vesicles released from many types that mediate The role keratinocyte-derived exosomes (KDEs) influencing signaling between skin terminals contribution genesis has not been explored. In this study, we characterized KDEs well-established high-fat diet (HFD) mouse model using primary adult keratinocyte cultures. We obtained highly enriched through size exclusion chromatography then analyzed molecular cargo proteomic analysis RNA sequencing. found significant differences protein microRNA content HFD compared control mice on regular (RD), including pathways involved axon guidance synaptic transmission. Additionally, an vivo conditional vesicle (EV) reporter model, demonstrated epidermal-originating GFP-tagged retrogradely trafficked into DRG neuron body. Overall, our study presents potential novel mode communication keratinocytes neurons skin, revealing possible for contributing axonal underlies neuropathic pain PDN. Moreover, therapeutic targets developing more effective, disease-modifying, better-tolerated topical interventions suffering PDN, one common untreatable peripheral neuropathies.
Language: Английский
Citations
3bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 5, 2024
ABSTRACT The molecular diversity of neurons and their synapses underlies the different responses plasticity profiles that drive all neural circuits behavior. While extent this has been partially revealed by transcriptomic proteomic profiling, combined studies neuronal transcripts proteins are limited. Here, we used microdissection mouse hippocampal subregions CA1 strata fluorescence-activated synaptosome sorting (FASS) to characterize from compartments with synaptic resolution. Parallel RNA-seq LC-MS/MS microdissections identified over 15,000 mRNA 10,000 proteins, revealing thousands local enrichment such as classes glutamate receptors voltage-gated potassium channels, myelin-associated molecules, adhesion molecules. Synaptosome analysis further specific molecules collagen, ribosome, solute carrier, receptor families at formed along neurons. By integrating protein data, defined clusters co-regulated neurofilament transporter mRNAs, found subsets mRNA-protein pairs strong correlation anti-correlation in abundance variation. Our findings comprise a rich resource on landscape hippocampus its is accessible syndive.org , highlight coordinated organization between regions, compartments, synapses.
Language: Английский
Citations
1bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 28, 2024
Abstract In Alzheimer’s disease (AD), amyloid-beta (Aβ) peptides are produced by proteolytic cleavage of the amyloid precursor protein (APP), which can occur during synaptic vesicle (SV) cycling at presynapses. Precisely how amyloidogenic APP processing may impair presynaptic proteostasis and to therapeutically target this process remains poorly understood. Using App knock-in mouse models early Aβ pathology, we found proteins with hampered degradation accumulate sites. At mild pathological stage, leads accumulation 42 inside SVs. To explore if targeting SVs modulates accumulation, investigated levetiracetam (Lev), a SV-binding small molecule drug that has shown promise in mitigating AD-related pathologies despite its mechanism action being unclear. We discovered Lev reduces levels decreasing SV2a-dependent manner. corrects SV cycling, results increased surface localization APP, where it favors via non-amyloidogenic pathway. metabolic stable isotopes mass spectrometry confirmed prevents production vivo. transgenic mice aggressive electrophysiological immunofluorescent microscopy analyses revealed treatment minimizes synapse loss. Finally, human Down syndrome brains have elevated proteins, confirming comparable deficit brains. Taken together, report highlights therapeutic potential modify stages AD represent promising strategy prevent pathology before irreversible damage occurs. One Sentence Summary modulating alters thus processing, highlighting for AD.
Language: Английский
Citations
1Neurobiology of Pain, Journal Year: 2024, Volume and Issue: 17, P. 100176 - 100176
Published: Dec. 17, 2024
Language: Английский
Citations
0Published: Jan. 1, 2024
Language: Английский
Citations
0